from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3136/PPE51

LFCtreatmentdescriptionclass of inhibitor

0.328

Amikacinug/mL Amikacintranslation

-1.415

Cap5-10ug/mL Capreomycintranslation

-1.362

Rox10-50 ug/mL Roxithromycintranslation

0.038

SM2-5 ug/mL Streptomycintranslation

-0.621

Tet5-10 ug/mL Tetracyclinetranslation

0.558

Rif0.2-5ug/mL Rifampicintranscription

0.200

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.560

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.508

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.609

CPZ10-50 ug/mL Chlorpromazinerespiration

0.639

Clofazimine10-13 ug/mL Clofaziminerespiration

0.126

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.676

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.230

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.184

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.735

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.321

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.014

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.625

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.053

KCN5-20 ug/mL Potassium cyaniderespiration

2.120

NaN30.2-2 mM Sodium aziderespiration

-0.454

Nigericin50 uM Nigericinrespiration

-0.478

TRC10-150 ug/mL Triclosanrespiration

1.286

TRZ10-25 ug/mL Thioridazinerespiration

-0.723

Valinomycin0.5-10 uM Valinomycinrespiration

3.689

ZnSO42 mM ZnSO4respiration

-0.064

menadione6-10 ug/mL Menadionerespiration

0.021

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.058

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.081

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.612

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.183

NRP_1Non-replicating persistence stage 1dosRassociated

-0.405

Amp0.2mg/mL AmpicillincellWall

0.514

Cephalexin20-100 ug/mL CephalexincellWall

0.449

Cerulenin0.32-5 ug/mL CerulenincellWall

0.393

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.630

EMB10-20 ug/mL EthambutolcellWall

0.225

Eta12-40 ug/mL EthionamidecellWall

0.130

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.189

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.132

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.442

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.081

BZA0.12 mg/mL BenzamidearomaticAmides

-0.004

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.132

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.550

H2O24 mM hydrogen peroxideDNAdamaging

0.071

Levo10 ug/mL LevofloxacinDNAdamaging

-0.790

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.105

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.249

Oflox5-10 ug/mL OfloxacinDNAdamaging

-2.235

UVUV-irradiationDNAdamaging

1.005

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.013

Antimycin12.5-50 ug/mL Antimycin A?

-0.668

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.413

PA_110-50 ug/mL Antitubercular compound PA-1?

0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.084

PA8240.2-2 ug/mL PA-824?

0.806

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.970

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.557

Verapamil50 uM Verapamil?

-0.687

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.056

methoxatin10-20 ug/mL Methoxatin?